BMY
Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +1.1% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 2.35M | $122.19M | n/a | −2 |
| Q2 2026 | 172 | +1 | 1.32B | $76.14B | +6 | −6 |
| Q1 2026 | 175 | +1 | 1.27B | $76.90B | +4 | −4 |
| Q4 2025 | 173 | +1 | 1.36B | $73.29B | +2 | n/a |
| Q3 2025 | 26 | 0 | 840.35M | $37.89B | n/a | −1 |
| Q2 2025 | 24 | +1 | 649.62M | $30.06B | +2 | −1 |
| Q1 2025 | 20 | 0 | 256.22M | $15.62B | +1 | −1 |
| Q4 2024 | 20 | -1 | 253.42M | $14.33B | n/a | −1 |
| Q3 2024 | 20 | +1 | 169.93M | $8.78B | +1 | n/a |
| Q2 2024 | 19 | n/a | 159.17M | $6.60B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 94.83M | -0.3% | $5.78B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 45.45M | +2.4% | $2.77B | 0.2% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passief) | 33.38M | -5.1% | $2.04B | 0.3% | ▼ Trim | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 23.73M | +297.0% | $1.45B | 0.3% | ▲ Add | 4 | SEC ↗ ×7 |
| 5 | PRIMECAP Management ✦ | 22.97M | +0.9% | $1.40B | 1.2% | ▲ Add | 4 | SEC ↗ |
| 6 | Dodge & Cox ✦ | 13.03M | -15.4% | $794.73M | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 5.97M | +49.0% | $364.05M | 0.4% | ▲ Add | 4 | SEC ↗ ×7 |
| 8 | T. Rowe Price ✦ | 5.79M | -23.1% | $353.10M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 9 | Bridgewater Associates ✦ | 2.34M | +13.6% | $142.79M | 0.7% | ▲ Add | 4 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 2.14M | +1250.6% | $130.53M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 2.07M | +95.6% | $126.50M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 1.95M | -74.9% | $119.07M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 758.57K | -43.9% | $46.27M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 14 | Millennium Management ✦ | 554.10K | -93.5% | $33.79M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 296.95K | +7.8% | $18.11M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 323.07K | +677.8% | $17.45M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 17 | Two Sigma Investments ✦ | 284.59K | +232.4% | $17.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 220.74K | -1.4% | $13.46M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 99.32K | -5.0% | $6.06M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 20 | Harris Associates (Oakmark) ✦ | 12.00K | Nieuw | $731,880 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Harris Associates (Oakmark) | $731,880 | 0.0% |
Verlaten
| Point72 Asset Management | $79.77M | was 0.2% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 6.60K aandelen, $400 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 6.25K aand · $403,498
Officer · 500 aand · $33,750
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie